- codeine phosphate
POM: Prescription only medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.
Below is a text only representation of the Patient Information Leaflet. The original leaflet can be viewed using the link above.
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet are: PL 29831/0050, PL 29831/0049, PL 29831/0048.
Codeine Phosphate 15mg, 30mg & 60mg Tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER
CODEINE PHOSPHATE TABLETS
Read all of this leaflet carefully before you start using this medicine.
In this leaflet:
1. What Codeine Phosphate Tablets are and what they are used for
2. Before you take Codeine Phosphate Tablets
3. How Codeine Phosphate Tablets should be taken
4. Possible side effects
5. How to store Codeine Phosphate Tablets
6. Further information
1. WHAT CODEINE PHOSPHATE TABLETS ARE AND WHAT THEY ARE USED FOR
This product contains codeine. Codeine belongs to a group of medicines called opioid analgesics which act to relieve pain. It can be used on its own or in combination with other pain killers such as paracetamol.
Codeine can be used in children over 12 years of age for the short-term relief of moderate pain that is not relieved by other painkillers such as paracetamol or ibuprofen alone.
These tablets are used to relieve pain, suppress coughs and treat diarrhoea.
2. BEFORE YOU TAKE CODEINE PHOSPHATE TABLETS
Codeine Phosphate Tablets should not be given if you:
Speak to your doctor before you take Codeine Phosphate Tablets if you:
If any of the above apply to you, speak to your doctor, nurse or pharmacist before you take Codeine Phosphate Tablets.
Contains lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
Warnings and precautions
Codeine is transformed to morphine in the liver by an enzyme. Morphine is the substance that produces pain relief. Some people have a variation of this enzyme and this can affect people in different ways. In some people, morphine is not produced or produced in very small quantities, and it will not provide enough pain relief. Other people are more likely to get serious side effects because a very high amount of morphine is produced. If you notice any of the following side effects, you must stop taking this medicine and seek immediate medical advice: slow or shallow breathing, confusion, sleepiness, small pupils, feeling or being sick, constipation, lack of appetite.
Children and adolescents
Use in children and adolescents after surgery
Codeine should not be used for pain relief in children and adolescents after removal of their tonsils or adenoids due to Obstructive Sleep Apnoea Syndrome.
Use in children with breathing problems
Codeine is not recommended in children with breathing problems, since the symptoms of morphine toxicity may be worse in these children.
Taking other medicines
It is very important that you inform your doctor if you are taking or have taken any other medicines, as some medicines may affect the way Codeine Phosphate Tablets work. In particular, tell your doctor if you are taking any of the following:
Food and drink and Codeine Phosphate Tablets
You should not drink alcohol whilst you are taking Codeine Phosphate Tablets, as they will increase its effects. Alcohol may increase the sedative effects of codeine phosphate and make you very sleepy.
Pregnancy and breast-feeding
You should not be given codeine if you are pregnant or think you might be pregnant unless you have discussed this with your doctor first. If you are given codeine during pregnancy and become dependent on it, there is a risk that the new-born baby may also be dependent and suffer from withdrawal symptoms following delivery. If you are given codeine during labour there is a risk that you could be sick and have breathing difficulties, or the baby could have difficulty starting breathing. Do not take codeine while you are breastfeeding. Codeine and morphine passes into breast milk.
Driving and using machines
You may feel drowsy and confused and you may develop blurred or double vision when you are taking Codeine Phosphate Tablets, so you should not drive or operate machinery.
This medicine can affect your ability to drive.
Do not drive whilst taking this medicine until you know how this medicine affects you.
It may be an offence to drive if your ability to drive safely is affected.
There is further information for patients who are intending to drive in Great Britain - go to https://www.gov.uk/drug-driving-law
3. HOW CODEINE PHOSPHATE TABLETS SHOULD BE GIVEN
The usual starting dose for adults and children aged 12 years or above for relief of mild to moderate pain is 30mg to 60mg every six hours, as needed. The usual adult starting dose for diarrhoea is 30mg, three or four times daily. No more than 240mg should be taken in 24 hours. In all cases, dosage will be reduced for elderly. Codeine Phosphate tablets should not be taken by children below the age of 12 years due to the risk of severe breathing problems. Codeine Phosphate Tablets are not recommended for the treatment of diarrhoea in children. You may need a reduced dose if you have kidney or liver problems. You may also be given a reduced dose if you suffer from any of the conditions listed above in the section headed ‘Speak to your doctor before you take Codeine Phosphate Tablets if you:’ Your doctor will decide the dose that is best for you. Always follow your doctor’s instructions completely. Also, follow any special instructions or warnings that appear on the label that the pharmacist has put on the package. If you do not understand or are in any doubt, ask your pharmacist.
Unless instructed differently, take your tablet(s) with a glass of water. If you have been given a blister pack, to obtain a tablet, press on the tablet from the blister (or bubble) pushing it through the foil. Do not remove the tablet from the blister until you are ready to take it.
This medicine should not be taken for more than 3 days. If the pain does not improve after 3 days, talk to your doctor for advice.
If you miss a dose of Codeine Phosphate Tablets
You should continue to take your medicine for as long as your doctor tells you to. If you forget a dose, take another as soon as you remember. If it is almost time for your next dose, then do not take the missed dose at all. NEVER double the next dose to make up for the one missed. Do not stop taking the medicine without telling your doctor first.
If treatment with Codeine Phosphate Tablets is stopped
You should always check with your doctor before the treatment is stopped. It is possible that you could become dependent on codeine and have withdrawal symptoms if it is stopped suddenly. This is more likely if you have a tendency for drug abuse or if you become dependent on Codeine Phosphate Tablets.
4. POSSIBLE SIDE EFFECTS
Like all medicines, codeine can cause side effects, but not everybody gets them. Tell your doctor or nurse immediately if you experience the following serious side effect:
Side effects that are common include:
Apart from constipation, these side effects tend to disappear with time. Side effects that are less common include:
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting systems listed below:
United Kingdom: Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard
Malta: ADR Reporting, Website: www.medicinesauthority.gov.mt/adrportal
By reporting side effects you can help provide more information on the safety of this medicine.
5. HOW TO STORE CODEINE PHOSPHATE TABLETS
Do not store above 25°C. Store in the original package or container in which they were given to you in order to protect from light. Do not transfer them to another container.
Keep out of the reach and sight of children.
Do not use Codeine Phosphate Tablets if the tablets show signs of discolouration.
Do not use Codeine Phosphate Tablets after the expiry date, which is stated on the carton. The expiry date refers to the last day of that month.
REMEMBER this medicine is for YOU only. Never give it to anyone else. It may harm them, even if the symptoms are the same as yours. Unless your doctor tells you to, do not keep tablets that you no longer need. Give them back to the pharmacist.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
6. FURTHER INFORMATION
What Codeine Phosphate Tablets contain
The active ingredient in Codeine Phosphate Tablets is Codeine Phosphate.
The tablets contain 15mg, 30mg or 60mg of the active ingredient.
Other ingredients are lactose, acacia spray-dried, maize starch, magnesium stearate and stearic acid.
What Codeine Phosphate Tablets looks like and contents of the pack
Codeine Phosphate 15mg Tablets are white circular tablets marked C15 on one face and CP on the other.
Codeine Phosphate 30mg Tablets are white circular tablets marked C30 on one face and CP on the other.
Codeine Phosphate 60mg Tablets are white circular tablets marked C60 on one face and CP on the other.
Codeine Phosphate 15mg, 30mg and 60mg Tablets are available in blister packs of 28, 30 and 100 tablets.
Not all strengths and pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder:
To listen to or request a copy of this leaflet in Braille, large print or audio please call, free of charge: 0800 198 5000 (UK Only)
Please be ready to give the following information:
Product name Reference number
Codeine Phosphate 15mg Tablets 29831/0048
Codeine Phosphate 30mg Tablets 29831/0049
Codeine Phosphate 60mg Tablets 29831/0050
This is a service provided by the Royal National Institute of Blind People.
This leaflet was last revised in 04/2015